KYTX Kyverna Therapeutics, Inc. - Common Stock
$8.97
Price · May 20, 2026
Fundamentals as of May 12, 2026
52W Range
$2–$14
59% of range
Analyst Rating
BUY
12 analysts
Price Target
$30
+230% upside
P/E (TTM)
-2.6
ROE
-77.4%
Net Profit Margin
—
KYTX Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$8.97
Market Cap
$568M
P/E (TTM)
-2.6
EPS (TTM)
$-3.64
Revenue (TTM)
—
Div Yield
—
ROE
-77.4%
Debt/Equity
—
52W Range
$2 – $14
KYTX Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
10-Year Performance Revenue, net income, margins and EPS trends
Revenue & Net Income
—
EPS
$-3.64
2023-12-31
→
2025-12-31
Free Cash Flow
$-154M
2024-12-31
→
2025-12-31
Margins
—
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
KYTX
Peer Median
P/E (TTM)
-2.6
15.7
P/B
2.4
4.1
Price / FCF
-3.7
—
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
KYTX
Peer Median
ROA
-53.9%
-63.5%
ROE
-77.4%
-91.3%
Financial Health Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
KYTX
Peer Median
Current Ratio
7.8
4.6
Quick Ratio
7.7
—
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
KYTX
Peer Median
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
KYTX
Peer Median
KYTX Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
BUY
12 analysts
- Strong Buy 4 33.3%
- Buy 7 58.3%
- Hold 1 8.3%
- Sell 0 0.0%
- Strong Sell 0 0.0%
12-Month Price Target
5 analysts · 2026-05-14
Median
$32.00
Mean
$29.60
← Below all targets
$8.97
Low
$20.00
High
$33.00
Median target
$32.00
+256.7%
Mean target
$29.60
+230.0%
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
0.08%
| Period | EPS Actual | EPS Est | Surprise |
|---|---|---|---|
| March 31, 2026 | $-0.66 | $-0.77 | 0.11% |
| Dec. 31, 2025 | $-0.80 | $-0.88 | 0.08% |
| Sept. 30, 2025 | $-0.85 | $-0.99 | 0.14% |
| June 30, 2025 | $-0.97 | $-1.06 | 0.09% |
| March 31, 2025 | $-1.03 | $-1.14 | 0.11% |
| Dec. 31, 2024 | $-0.88 | $-0.85 | -0.03% |
Peer Comparison Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| KYTX | $568M | -2.6 | — | — | -77.4% | — |
| ALT | $400M | -3.6 | 105.0% | -214861.0% | -45.6% | — |
| CBIO | $327M | -24.2 | -86.7% | -1419.6% | -90.0% | — |
| RIGL | $784M | 2.2 | 64.1% | 124.7% | 155.1% | — |
| TECX | $391M | -5.2 | — | — | -27.7% | — |
| XOMA | $315M | 18.2 | 83.1% | 60.8% | 43.5% | — |
| STRO | $99M | -0.5 | 65.2% | -186.5% | 232.2% | — |
| PRME | $626M | -2.6 | 55.3% | -4342.4% | -221.4% | — |
| PROK | — | — | 1075.0% | -7725.2% | 6.9% | — |
| IMMX | $277M | -5.9 | — | — | -59.8% | — |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement 13
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| R&D Expense | $134M | $112M | $50M | |
| SG&A Expense | $36M | $30M | $12M | |
| Operating Expenses | $170M | $143M | $62M | |
| Operating Income | $-170M | $-143M | $-62M | |
| Interest Income | $9M | $15M | $2M | |
| Other Non-op | $-85.0K | $-90.0K | $-55.0K | |
| Income Tax | $0 | $0 | $0 | |
| Net Income | $-161M | $-127M | $-60M | |
| EPS (Basic) | $-3.64 | $-3.33 | $-89.61 | |
| EPS (Diluted) | $-3.64 | $-3.33 | $-89.61 | |
| Shares (Basic) | 44,259,999 | 38,334,571 | 673,622 | |
| Shares (Diluted) | 44,259,999 | 38,334,571 | 673,622 | |
| EBITDA | $-168M | $-140M | · |
Balance Sheet 19
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & Equivalents | $124M | $97M | $35M | |
| Short-term Investments | $155M | $189M | $23M | |
| Prepaid Expense | $4M | $5M | $3M | |
| Current Assets | $283M | $291M | $61M | |
| PP&E (Net) | $2M | $3M | $2M | |
| PP&E (Gross) | $5M | $7M | $5M | |
| Accum. Depreciation | $4M | $4M | $2M | |
| Other Non-current Assets | $5M | $3M | $3M | |
| Total Assets | $294M | $305M | $75M | |
| Accounts Payable | $5M | $5M | $4M | |
| Current Liabilities | $36M | $34M | $20M | |
| Capital Leases | $320.0K | $4M | $5M | |
| Total Liabilities | $62M | $38M | $26M | |
| Common Stock | $1.0K | $0 | · | |
| Retained Earnings | $-425M | $-264M | $-136M | |
| AOCI | $97.0K | $105.0K | $4.0K | |
| Stockholders' Equity | $232M | $267M | $-13M | |
| Liabilities + Equity | $294M | $305M | $75M | |
| Shares Outstanding | 60,389,893 | 43,214,918 | 1,250,103 |
Cash Flow 12
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| D&A | $2M | $2M | $2M | |
| Stock-based Comp | $10M | $8M | $2M | |
| Other Non-cash | $-4M | $3M | · | |
| Operating Cash Flow | $-154M | $-114M | $-52M | |
| CapEx | $5.0K | $2M | $621.0K | |
| Investing Cash Flow | $40M | $-161M | $-9M | |
| Stock Issued | $17M | $0 | · | |
| Net Stock Activity | $17M | · | · | |
| Financing Cash Flow | $141M | $337M | $58M | |
| Net Change in Cash | $27M | $62M | $-3M | |
| Taxes Paid | $0 | $0 | · | |
| Free Cash Flow | $-154M | $-116M | · |
Profitability 2
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| ROA | -53.9% | -67.1% | · | |
| ROE | -77.4% | -44.8% | · |
Liquidity & Solvency 2
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Current Ratio | 7.8 | 8.6 | · | |
| Quick Ratio | 7.7 | 8.5 | · |
Valuation (TTM) 8
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Net Income TTM | $-161M | $-127M | $-60M | |
| Market Cap | $568M | $162M | · | |
| P/E | -2.6 | -1.1 | · | |
| P/B | 2.4 | 0.6 | · | |
| P / Tangible Book | 2.4 | 0.6 | · | |
| P / Cash Flow | -3.7 | -1.4 | · | |
| P / FCF | -3.7 | -1.4 | · | |
| Earnings Yield | -38.7% | -89.0% | · |
Income Statement 13
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $30M | $30M | $30M | $36M | $37M | $33M | $29M | $27M | $22M | $17M | $14M | $10M | $9M | |
| SG&A Expense | $11M | $9M | $8M | $9M | $10M | $8M | $10M | $6M | $7M | $4M | $3M | $3M | $3M | |
| Operating Expenses | $41M | $39M | $39M | $44M | $47M | $41M | $39M | $33M | $29M | $21M | $16M | $13M | $11M | |
| Operating Income | $-41M | $-39M | $-39M | $-44M | $-47M | $-41M | $-39M | $-33M | $-29M | $-21M | $-16M | $-13M | $-11M | |
| Interest Expense | · | · | · | · | · | · | · | $39.0K | $44.0K | · | · | $46.0K | $44.0K | |
| Interest Income | $2M | $2M | $2M | $2M | $3M | $4M | $4M | $5M | $3M | $789.0K | $880.0K | $264.0K | $349.0K | |
| Other Non-op | $-21.0K | $16.0K | $-53.0K | $-21.0K | $-27.0K | $4.0K | $-45.0K | $-23.0K | $-26.0K | $-32.0K | $-13.0K | $-7.0K | $-3.0K | |
| Net Income | $-40M | $-38M | $-37M | $-42M | $-45M | $-37M | $-34M | $-29M | $-27M | $-21M | $-15M | $-13M | $-11M | |
| EPS (Basic) | $-0.66 | $-0.79 | $-0.85 | $-0.97 | $-1.03 | $-0.74 | $-0.80 | $-0.67 | $-1.12 | $-33.38 | $-23.27 | $-20.86 | $-12.10 | |
| EPS (Diluted) | $-0.66 | $-0.79 | $-0.85 | $-0.97 | $-1.03 | $-0.74 | $-0.80 | $-0.67 | $-1.12 | $-33.38 | $-23.27 | $-20.86 | $-12.10 | |
| Shares (Basic) | 60,434,200 | -85,596,310 | 43,415,367 | 43,225,365 | 43,215,577 | -71,701,058 | 43,155,858 | 43,125,709 | 23,754,062 | -1,539,883 | 664,656 | 627,589 | 921,260 | |
| Shares (Diluted) | 60,434,200 | -85,596,310 | 43,415,367 | 43,225,365 | 43,215,577 | -71,701,058 | 43,155,858 | 43,125,709 | 23,754,062 | -1,539,883 | 664,656 | 627,589 | 921,260 | |
| EBITDA | $-41M | · | $-39M | $-44M | $-47M | · | $-39M | $-33M | $-29M | · | · | · | · |
Balance Sheet 20
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $32M | $124M | $34M | $53M | $57M | $97M | $105M | $132M | $224M | $35M | · | · | · | |
| Short-term Investments | $204M | $155M | $137M | $158M | $186M | $189M | $217M | $215M | $146M | $23M | · | · | · | |
| Prepaid Expense | $5M | $4M | $4M | $3M | $5M | $5M | $4M | $3M | $6M | $3M | · | · | · | |
| Current Assets | $242M | $283M | $175M | $214M | $248M | $291M | $325M | $349M | $375M | $61M | · | · | · | |
| PP&E (Net) | $1M | $2M | $2M | $2M | $2M | $3M | $3M | $3M | $3M | $2M | · | · | · | |
| PP&E (Gross) | $5M | $5M | $5M | $6M | $6M | $7M | $6M | $6M | $5M | $5M | · | · | · | |
| Accum. Depreciation | $4M | $4M | $4M | $4M | $4M | $4M | $3M | $3M | $3M | $2M | · | · | · | |
| Other Non-current Assets | $5M | $5M | $5M | $4M | $4M | $3M | $2M | $1M | $1M | $3M | · | · | · | |
| Total Assets | $257M | $294M | $187M | $227M | $261M | $305M | $339M | $363M | $390M | $75M | · | · | · | |
| Accounts Payable | $12M | $5M | $3M | $10M | $8M | $5M | $10M | $5M | $7M | $4M | · | · | · | |
| Current Liabilities | $30M | $36M | $34M | $40M | $33M | $34M | $31M | $23M | $22M | $20M | · | · | · | |
| Capital Leases | $7M | $320.0K | $1M | $2M | $3M | $4M | $5M | $6M | $6M | $5M | · | · | · | |
| Other Non-current Liabilities | · | · | · | · | · | · | $296.0K | · | · | · | · | · | · | |
| Total Liabilities | $61M | $62M | $35M | $42M | $37M | $38M | $36M | $30M | $29M | $26M | · | · | · | |
| Common Stock | $1.0K | $1.0K | · | · | · | $0 | · | · | · | · | · | · | · | |
| Retained Earnings | $-465M | $-425M | $-387M | $-350M | $-308M | $-264M | $-226M | $-192M | $-163M | $-136M | · | · | · | |
| AOCI | $-96.0K | $97.0K | $29.0K | $-20.0K | $-1.0K | $105.0K | $153.0K | $-37.0K | $-1.0K | $4.0K | · | · | · | |
| Stockholders' Equity | $196M | $232M | $152M | $184M | $224M | $267M | $303M | $334M | $361M | $-131M | · | · | · | |
| Liabilities + Equity | $257M | $294M | $187M | $227M | $261M | $305M | $339M | $363M | $390M | $75M | · | · | · | |
| Shares Outstanding | 60,532,500 | 60,389,893 | 43,794,087 | 43,244,930 | 43,218,873 | 43,214,918 | 43,167,337 | 43,146,852 | 43,115,244 | 1,250,103 | · | · | · |
Cash Flow 9
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $351.0K | $368.0K | $415.0K | $515.0K | $501.0K | $563.0K | $558.0K | $530.0K | $482.0K | $462.0K | $438.0K | $413.0K | $394.0K | |
| Stock-based Comp | $3M | $3M | $3M | $3M | $2M | $1M | $3M | $1M | $2M | $784.0K | $521.0K | $447.0K | $468.0K | |
| Other Non-cash | $-5M | · | · | · | $-3M | · | · | · | $-2M | · | · | · | · | |
| Operating Cash Flow | $-42M | $-34M | $-43M | $-32M | $-45M | $-37M | $-27M | $-24M | $-26M | $-19M | $-11M | $-11M | $-11M | |
| CapEx | · | $-1.0K | $2.0K | $4.0K | $0 | $532.0K | $102.0K | $1M | $543.0K | $334.0K | $256.0K | $3.0K | $28.0K | |
| Investing Cash Flow | $-50M | $-17M | $23M | $29M | $6M | $29M | $676.0K | $-68M | $-123M | $32M | $-54M | $-3.0K | $14M | |
| Financing Cash Flow | $-101.0K | $141M | $1M | $-649.0K | $-414.0K | $-215.0K | $-152.0K | $-569.0K | $338M | $-1M | $35M | $25M | $-144.0K | |
| Net Change in Cash | $-92M | $90M | $-19M | $-3M | $-40M | $-8M | $-27M | $-93M | $190M | $12M | $-30M | $14M | $2M | |
| Free Cash Flow | · | · | · | · | $-45M | · | · | · | $-26M | · | · | · | · |
Profitability 2
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -15.3% | · | -14.0% | -14.3% | -13.7% | · | -20.3% | -15.9% | -13.7% | · | · | · | · | |
| ROE | -18.9% | · | -16.2% | -16.2% | -15.3% | · | -22.8% | -17.3% | -14.8% | · | · | · | · |
Liquidity & Solvency 3
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 8.1 | · | 5.2 | 5.4 | 7.4 | · | 10.5 | 14.9 | 17.2 | · | · | · | · | |
| Quick Ratio | 8.0 | · | 5.1 | 5.3 | 7.3 | · | 10.4 | 14.7 | 16.9 | · | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | -857.3 | -667.2 | · | · | · | · |
Valuation (TTM) 8
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-163M | · | $-158M | $-150M | $-135M | · | $-105M | $-84M | $-66M | · | · | · | · | |
| Market Cap | $522M | · | $263M | $133M | $83M | · | $211M | $324M | $1.07B | · | · | · | · | |
| P/E | -2.5 | · | -1.6 | -0.9 | -0.5 | · | -0.2 | -0.2 | -0.4 | · | · | · | · | |
| P/B | 2.7 | · | 1.7 | 0.7 | 0.4 | · | 0.7 | 1.0 | 3.0 | · | · | · | · | |
| P / Tangible Book | 2.7 | · | 1.7 | 0.7 | 0.4 | · | 0.7 | 1.0 | 3.0 | · | · | · | · | |
| P / Cash Flow | -12.6 | · | · | · | -1.9 | · | · | · | -42.0 | · | · | · | · | |
| P / FCF | · | · | · | · | -1.9 | · | · | · | -41.1 | · | · | · | · | |
| Earnings Yield | -40.7% | · | -60.8% | -113.0% | -187.6% | · | -528.8% | -612.3% | -230.9% | · | · | · | · |
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
Income Statement
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Net Income | $-161M | $-127M | $-60M |
| Diluted EPS | $-3.64 | $-3.33 | $-89.61 |
Balance Sheet
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Current Ratio | 7.8 | 8.6 | — |
| Quick Ratio | 7.7 | 8.5 | — |
Cash Flow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Free Cash Flow | $-154M | $-116M | — |
Latest News Recent headlines mentioning this company
My Metrics Your personal watchlist — selected rows from Full Fundamentals
📊
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.